Results 191 to 200 of about 34,901 (267)

Meropenem/Vaborbactam: β-Lactam/β-Lactamase Inhibitor Combination, the Future in Eradicating Multidrug Resistance. [PDF]

Antibiotics (Basel), 2023
Duda-Madej A, Viscardi S, Topola E.
europepmc   +1 more source

Structure-activity relationship study and optimisation of 2-aminopyrrole-1-benzyl-4,5-diphenyl-1 H -pyrrole-3-carbonitrile as a broad spectrum metallo-β-lactamase inhibitor

, 2017
Ross P. McGeary, Daniel T.C. Tan, Christopher Selleck, Marcelo Monteiro Pedroso, Hanna E. Sidjabat, Gerhard Schenk   +5 more
openalex   +2 more sources

Early Insights into the Interactions of Different β-Lactam Antibiotics and β-Lactamase Inhibitors against Soluble Forms of Acinetobacter baumannii PBP1a and Acinetobacter sp. PBP3 [PDF]

, 2012
Krisztina M. Papp‐Wallace, Baui Senkfor, Julian A. Gatta, Weirui Chai, Magdalena A. Taracila, Veerabahu Shanmugasundaram, Seungil Han, Richard P. Zaniewski, Brian M. Lacey, Andrew P. Tomaras, Marion Skalweit, Michael E. Harris, Louis B. Rice, John D. Buynak, Robert A. Bonomo   +14 more
openalex   +1 more source

Synthesis of 2-Carbamoyl-4-Oxo-1,5-Diazabicyclo [3.2.1] Octane Derivatives as a Possible Inhibitors of Serine β-Lactamases

, 2018
Haiyu Wang, Abbas Gholipour Shilabin
openalex   +1 more source

Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 β-lactamase [PDF]

, 2013
Abdelmonaem Messaoudi, Hatem Belguith, Jeannette Ben Hamida   +2 more
openalex   +1 more source

Combinations comprising dual β-lactams and a β-lactamase inhibitor achieve optimal synergistic inhibition of <i>Mycobacterium abscessus</i> growth. [PDF]

Antimicrob Agents Chemother
Rimal B, Xie Y, Panthi CM, Devlin KL, Beatty KE, Lamichhane G.   +5 more
europepmc   +1 more source

Clinical efficacy, safety and pharmacokinetics of novel β-lactam/β-lactamase inhibitor combinations: a systematic review. [PDF]

JAC Antimicrob Resist
Alarcia-Lacalle A, Canut-Blasco A, Solinís MÁ, Isla A, Rodríguez-Gascón A.   +4 more
europepmc   +1 more source

Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023). [PDF]

Antibiotics (Basel)
Sader HS, Winkler ML, Papp-Wallace KM, Mendes RE, Castanheira M.   +4 more
europepmc   +1 more source

156. Using Whole Genome Sequencing to Genetically Profile and Analyze Escherichia coli Isolates with Varying Resistance to β-Lactam/β-lactamase Inhibitor Combinations

, 2022
Marc Gohel, Hatim Amiji, Benjamin Strope, Pranoti Sahasrabhojane, David E. Greenberg, William C. Shropshire, Samuel A. Shelburne   +6 more
openalex   +1 more source

The emerging concern of IMP variants being resistant to the only IMP-type metallo-β-lactamase inhibitor, xeruborbactam. [PDF]

Antimicrob Agents Chemother
Le Terrier C, Drusin SI, Nordmann P, Pitout J, Peirano G, Vila AJ, Moreno DM, Poirel L.   +7 more
europepmc   +1 more source